Page last updated: 2024-10-15

phosphoserine and Fanconi Anemia

phosphoserine has been researched along with Fanconi Anemia in 1 studies

Phosphoserine: The phosphoric acid ester of serine.

Fanconi Anemia: Congenital disorder affecting all bone marrow elements, resulting in ANEMIA; LEUKOPENIA; and THROMBOPENIA, and associated with cardiac, renal, and limb malformations as well as dermal pigmentary changes. Spontaneous CHROMOSOME BREAKAGE is a feature of this disease along with predisposition to LEUKEMIA. There are at least 7 complementation groups in Fanconi anemia: FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, and FANCL. (from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=227650, August 20, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taniguchi, T1
Garcia-Higuera, I1
Xu, B1
Andreassen, PR1
Gregory, RC1
Kim, ST1
Lane, WS1
Kastan, MB1
D'Andrea, AD1

Other Studies

1 other study available for phosphoserine and Fanconi Anemia

ArticleYear
Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways.
    Cell, 2002, May-17, Volume: 109, Issue:4

    Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Line, Trans

2002